Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2003
05/20/2003US6566080 Assay for and uses of peptide hormone receptor agonists
05/20/2003US6566079 Methods for analyzing protein binding events
05/20/2003US6566078 36P6D5: secreted tumor antigen
05/20/2003US6566077 Qualitative or quantitative analysis of immunoglobulin; generate solid support, incubate with immunoglobulin mixture, wash microtiter plate, detect complexed immunoglobulin
05/20/2003US6566076 Detection and diagnosis of conditions associated with lung injury
05/20/2003US6566075 Methods for detecting human platelet-derived growth factor receptor agonists and antagonists
05/20/2003US6566072 Diagnosing mammary gland cancer in humans; obtain tissue sample, recover proteins, incubate with antibody, detect presence bound antibody, amplified presence of boubd antibody indicates cancer
05/20/2003US6566066 Aquaporin-8 variant
05/20/2003US6566063 Diagnosing cancer in cells; obtain cells, monitor expression of gland-specific transcription factor, compare to control, evaluate for cancer
05/20/2003US6566053 Diagnosing tumors in humans; obtain sample, extract nucleotide sequences, incubate with probe, detect hybridization to microsatellite sequences, presence of microsattelite sequences indicates cancer
05/20/2003US6566052 Efficient algorithm for PCR testing of blood samples
05/20/2003US6566051 Apparatus for use in the detection of preferential particles in sample
05/20/2003US6566049 Enzymatic approach for analytical method development
05/20/2003US6566047 Method for identifying neurite-growth promoting agents
05/20/2003US6565858 Human ADAMTS-1 protein and pharmaceutical composition
05/20/2003US6565857 Coding human leukocyte antigen; anticancer, antitumor agent
05/20/2003US6565856 Polypeptide; inducting immunology response
05/20/2003US6565843 Protein-induced tissue morphogenesis
05/20/2003US6565827 Anticarcinogenic agents
05/20/2003US6565813 Layout containing hydrophilic, hydrophobic zones; controlling evaporation
05/20/2003US6565809 Specimen processing system
05/20/2003US6565789 Methods for producing low binding surfaces
05/20/2003US6565738 Analyzing of liver disease; measuring alanine aminotransferase
05/20/2003US6564657 Sampling method and apparatus for consistency measurement
05/20/2003US6564655 Analytical sampling device
05/20/2003US6564646 Measuring method for determining the biaxial shaping behavior of metallic materials, more particularly sheet metal
05/20/2003US6564633 Measurement method and system for a humidity or gas concentration sensor
05/20/2003US6564624 Fuel driveability index sensor and method
05/20/2003CA2412207A1 Stabilized tetrazolium reagent compositions and methods for using the same
05/20/2003CA2412198A1 Stabilized tetrazolium-phenazine reagent compositions and methods for using the same
05/20/2003CA2363469A1 Diagnosis of the parkinsonian condition
05/20/2003CA2199515C Automated molecular biological diagnostic system
05/20/2003CA2198946C Fluid testing sensor for use in dispensing instrument
05/20/2003CA2187690C Labeled reagents for use in immunoassays and fluorescent compounds and complexes used therein
05/20/2003CA2157665C An optical arrangement for flow cytometers
05/20/2003CA2101166C Method for detection of anti-rna-antibodies
05/20/2003CA2075695C Monoclonal antibodies to sulfonated polymers
05/16/2003CA2407575A1 Oligonucleotide-immobilized substrate for detecting methylation
05/15/2003WO2003040992A1 Methods and systems for the identification of components of mammalian biochemical networks as targets for therapeutic agents
05/15/2003WO2003040935A1 Multiport non-blocking high capacity atm and packet switch
05/15/2003WO2003040729A2 Method for identifying pathogenic particles in an organism
05/15/2003WO2003040728A2 Method and apparatus for the determination of glucose
05/15/2003WO2003040727A2 Use of oxidic nanoparticles
05/15/2003WO2003040726A2 Screening for hepatitis c virus entry inhibitors
05/15/2003WO2003040725A2 Method of determining whether a patient afflicted with cancer can be treated by a therapeutic agent that targets the 17-1a antigen
05/15/2003WO2003040724A1 Method for prediction or prognosis of the efficacy of a tumour treatment
05/15/2003WO2003040723A1 Method for rehabilitating an organism with slow viral infection
05/15/2003WO2003040722A1 Means and methods for the detection of immunoglobulin capable of binding to mycobacterium antigen
05/15/2003WO2003040721A1 Device and method for microchip based enzyme linked immunosorbent assay (elisa)
05/15/2003WO2003040720A1 Multiple virus reaction assay
05/15/2003WO2003040719A1 Biological marker for stress states
05/15/2003WO2003040716A1 Thin film ethanol sensor and a process for the preparation
05/15/2003WO2003040715A1 Sample preparation methods for maldi mass spectrometry
05/15/2003WO2003040705A2 A manifold device comprising a plurality of flow cells and fiber-optic probes for dissolution systems, and method
05/15/2003WO2003040704A1 Spectroscopic fluid analyzer
05/15/2003WO2003040701A1 Method of particle characterization based on fluorescence imaging
05/15/2003WO2003040700A1 Hydrophobic surface chip
05/15/2003WO2003040698A1 Container and testing device for sport balls
05/15/2003WO2003040695A2 Protein knobs
05/15/2003WO2003040694A2 Enzymatic cycling assays for homocysteine and cystathionine
05/15/2003WO2003040691A2 Soluble cd40l(cd154) as a prognostic marker of atherosclerotic diseases
05/15/2003WO2003040689A2 Compositions, methods and kits for determining the presence of mycoplasma pneumoniae and/or mycoplasma genitalium in a test sample
05/15/2003WO2003040685A2 Diagnosis demyelinating or spongiform disease
05/15/2003WO2003040684A2 Screening for antiviral affecting signal peptidase
05/15/2003WO2003040679A2 Reversibly binding a fluorophore to a surface for the purpose of detecting ligate/ligand association events by fluorescence quenching
05/15/2003WO2003040678A2 Fluorescence quenching used to detect ligate/ligand association events in electrical fields
05/15/2003WO2003040670A2 Method of identifying energy transfer sensors for analytes
05/15/2003WO2003040658A2 Mass flow control in a process gas analyzer
05/15/2003WO2003040435A2 Rhodium electrocatalyst and method of preparation
05/15/2003WO2003040415A1 Hiv-1 vpr interactions with mitochondrial apoptosis inducing factor and methods of using the same
05/15/2003WO2003040414A1 Method and device for detecting and monitoring alcoholism and related diseases using microarrays
05/15/2003WO2003040413A1 System for detecting biological materials in a sample
05/15/2003WO2003040409A1 Novel germinal center kinase proteins, compositions, and methods of use
05/15/2003WO2003040406A2 Diagnosis of clinical infection of a wound
05/15/2003WO2003040404A1 Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
05/15/2003WO2003040403A1 Functional assay for genes involved in xylogenesis
05/15/2003WO2003040401A2 General screening method for ligand-protein interactions
05/15/2003WO2003040394A2 Production of recombinant proteins in vivo and use for generating antibodies
05/15/2003WO2003040391A2 Method for producing and identifying soluble protein domains
05/15/2003WO2003040390A2 Protease assay for therapeutic drug monitoring
05/15/2003WO2003040389A2 Method for identifying endogenic and exogenic substances in an organism
05/15/2003WO2003040387A2 Methods for identifying active substances for pip92-mediated apoptosis modulation
05/15/2003WO2003040386A2 Reaction chambers containing complex stable reagent formulations and test kit for detection and isolation of pathogenic microbial nucleic acids
05/15/2003WO2003040385A2 Membrane protein interaction assays
05/15/2003WO2003040384A1 Recombinant antibodies for the detection and neutralization of anthrax toxin
05/15/2003WO2003040371A1 Novel g protein-coupled receptor protein and dna thereof
05/15/2003WO2003040361A1 Stereostructure of dna recombination repair enzyme and utilization thereof
05/15/2003WO2003040347A2 Baalc expression as a diagnostic marker for acute leukemia
05/15/2003WO2003040329A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/15/2003WO2003040317A2 Lung cancer therapeutics and diagnostics
05/15/2003WO2003040315A2 Method of encoding characteristics of a biological sample
05/15/2003WO2003040303A2 Functional assay for agonist activation of receptors
05/15/2003WO2003040299A2 Method of selecting hla-dp4 ligands and the applications thereof
05/15/2003WO2003040296A2 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis
05/15/2003WO2003040288A2 Isotopically coded affinity markers 3
05/15/2003WO2003040287A2 Isotope-coded affinity tag
05/15/2003WO2003040187A1 Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof
05/15/2003WO2003040186A1 Monoclonal antibody against canine distemper virus and method of diagnosis of distemper
05/15/2003WO2003040183A2 Compounds for the diagnosis/prevention/treatment of alzheimer's disease
05/15/2003WO2003040169A2 Human monoclonal antibodies to dendritic cells
1 ... 2588 2589 2590 2591 2592 2593 2594 2595 2596 2597 2598 2599 2600 2601 2602 2603 2604 2605 2606 2607 2608 ... 3937